BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6972527)

  • 1. [T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy].
    Kogosova LS; Bal'tseva LV; Petrashenko AI
    Probl Tuberk; 1981 Feb; (2):24-8. PubMed ID: 6972527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA; Vasil'eva FR; Kurbanova RR; Stepanenko RN; Ubaĭdullaev AM
    Probl Tuberk; 1990; (3):16-8. PubMed ID: 2367502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional status of lymphocytes in adolescents with tuberculosis during complex therapy].
    Nikitina OI; Skvortsova RG; Enamirovskaia AV; Slepushkin VD
    Probl Tuberk; 1987; (7):26-9. PubMed ID: 3498938
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of glucocorticosteroid hormones on T lymphocytes in patients with pulmonary tuberculosis].
    Basov PV
    Probl Tuberk; 1989; (4):30-3. PubMed ID: 2786631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological indicators in newly detected pulmonary tuberculosis with different degree of infiltration].
    Khomenko AG; Averbakh MM; Gergert VIa; Chukanov VI; Protopopova NM
    Probl Tuberk; 1981 Feb; (2):19-24. PubMed ID: 6972526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood T-lymphocyte functional activity in pulmonary tuberculosis patients undergoing chemotherapeutic agent and vitamin treatment].
    Volosevich GV
    Probl Tuberk; 1982 Mar; (3):47-50. PubMed ID: 6979747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological status of newly detected patients with destructive pulmonary tuberculosis].
    Khomenko AG; Averbakh MM; Rudoĭ NM; Litvinov VI; Gergert VIa
    Probl Tuberk; 1979 Apr; (4):13-7. PubMed ID: 312495
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis.
    Khomenko AG; Averbach MM; Litvinov VI; Gergert VJ; Chukanov VI
    Bull World Health Organ; 1984; 62(5):763-71. PubMed ID: 6391716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological indicators in patients with pulmonary tuberculosis in the presence of drug-resistant Mycobacteria].
    Kuz'mina NV
    Probl Tuberk; 1996; (3):38-9. PubMed ID: 8754879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of vitamins on general condition of the T- and B-immunity systems during antibacterial treatment of pulmonary tuberculosis].
    Volosevich GV
    Probl Tuberk; 1978 Oct; (10):36-9. PubMed ID: 309606
    [No Abstract]   [Full Text] [Related]  

  • 12. [State of the serotonin-monoamine oxidase-serotoninopexy system and its relation to immunological indicators in patients with pulmonary tuberculosis].
    Chernushenko EF; Karnakh RI; Mamolat AS
    Vrach Delo; 1985 Apr; (4):66-9. PubMed ID: 3874478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic status of patients with pulmonary tuberculosis and pneumonia].
    Knoring BE; Saburenkova EP; Feĭgin MI; Cherven-Vodali GA
    Probl Tuberk; 1992; (7-8):50-3. PubMed ID: 1488444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T- and B-rossette forming lymphocytes in the peripheral blood of patients with pulmonary tuberculosis].
    Vakhidova GA
    Probl Tuberk; 1977 Nov; (11):80-3. PubMed ID: 305046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulatory activity of lymphocytes in patients with pulmonary tuberculosis].
    Machkova NA
    Probl Tuberk; 1991; (5):57-9. PubMed ID: 1681533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity parameters in children with prior intrathoracic tuberculosis].
    Elufimova VF; Mitinskaia LA; Iukhimenko NV; Romanova RIu; Abramova ZP; Dem'ianenko NV; Baenskiĭ AV
    Probl Tuberk; 2000; (2):23-5. PubMed ID: 10838903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B-lymphocytes and the level of circulating immune complexes in pulmonary tuberculosis patients treated with chemotherapy and vitamins].
    Volosevich GV
    Probl Tuberk; 1983 Jul; (7):20-2. PubMed ID: 6605532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of immunity in patients with destructive pulmonary tuberculosis].
    Shenderova RI; Sakharova IIa; Machkova NA; Iakunova OA
    Probl Tuberk; 1992; (7-8):48-50. PubMed ID: 1488443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.